We are live on ! Find out more

1,565 hedge funds and large institutions have $109B invested in Merck in 2013 Q4 according to their latest regulatory filings, with 187 funds opening new positions, 581 increasing their positions, 627 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 187 | Existing positions closed: 70

46% more call options, than puts

Call options by funds: $1.39B | Put options by funds: $953M

7% more funds holding

Funds holding: 1,4691,565 (+96)

6% more capital invested

Capital invested by funds: $103B → $109B (+$5.89B)

0.21% more ownership

Funds ownership: 77.81%78.01% (+0.21%)

7% less repeat investments, than reductions

Existing positions increased: 581 | Existing positions reduced: 627

3% less funds holding in top 10

Funds holding in top 10: 117113 (-4)

Holders
1,565
Holders Change
+96
Holders Change %
+6.54%
% of All Funds
45.43%
Holding in Top 10
113
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-3.42%
% of All Funds
3.28%
New
187
Increased
581
Reduced
627
Closed
70
Calls
$1.39B
Puts
$953M
Net Calls
+$434M
Net Calls Change
+$103M
Name Holding Trade Value Shares
Change
Change in
Stake
BNP Paribas Asset Management
201
BNP Paribas Asset Management
France
$51.7M -$5.06M -110,709 -9%
TSU
202
TD Securities (USA)
New York
$51.6M +$1.39M +30,332 +3%
Hotchkis & Wiley Capital Management
203
Hotchkis & Wiley Capital Management
California
$51M -$1.93M -42,234 -4%
NTCOC
204
Northern Trust Company of Connecticut
Connecticut
$50.5M +$5.91M +129,393 +14%
DRZID
205
DePrince Race & Zollo Inc (DRZ)
Florida
$50.4M +$48.2M +1,054,676 New
SIA
206
Sit Investment Associates
Minnesota
$50.3M -$457K -9,988 -0.9%
CCM
207
Camber Capital Management
Massachusetts
$49.6M +$47.4M +1,037,834 New
AACR
208
ACR Alpine Capital Research
Missouri
$49.5M +$6.32M +138,275 +15%
VLKIM
209
Van Lanschot Kempen Investment Management
Netherlands
$49.4M +$46.4M +1,014,003 New
BP
210
BBR Partners
New York
$48.6M
Fifth Third Bancorp
211
Fifth Third Bancorp
Ohio
$48.4M -$121K -2,639 -0.3%
MAMU
212
Marathon Asset Management (UK)
United Kingdom
$46.7M -$6.56M -143,453 -13%
DCLA
213
Douglas C. Lane & Associates
New York
$46.1M -$2.51M -54,878 -5%
SAM
214
Shell Asset Management
Netherlands
$46M +$1.17M +25,632 +3%
Los Angeles Capital Management
215
Los Angeles Capital Management
California
$45.7M -$15.2M -333,125 -26%
Fidelity International
216
Fidelity International
Bermuda
$45.6M -$250M -5,479,418 -85%
SC
217
Samlyn Capital
New York
$45.3M +$43.3M +948,126 New
GH
218
GAM Holding
Switzerland
$44.7M +$10.8M +235,820 +34%
NRECA
219
National Rural Electric Cooperative Association
Virginia
$44.5M
BCM
220
Becker Capital Management
Oregon
$44.1M -$6.14M -134,221 -13%
SCP
221
Seizert Capital Partners
Michigan
$43.8M +$6.55M +143,253 +19%
FRM
222
Foundation Resource Management
Arkansas
$43.7M -$158K -3,451 -0.4%
MIH
223
Madison Investment Holdings
Wisconsin
$43.7M +$358K +7,834 +0.9%
OI
224
Oakbrook Investments
Illinois
$43.6M +$12.2M +266,846 +41%
HIMCH
225
Hartford Investment Management Co (HIMCO)
Connecticut
$42.2M -$2.9M -63,484 -7%

MRK Hedge Fund Activity: Q4 2013 in Review

1,565 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2013, worth a combined $109B — up 5.7% from $103B a quarter earlier.

Buyers outnumbered sellers: 187 funds opened new MRK positions and 70 closed out — a net gain of 117 holders — while 581 added to existing stakes and 627 trimmed.

The largest buyer was Capital World Investors, adding an estimated $561M. The largest seller was Fidelity Investments, cutting an estimated $386M.

  • 1,565 institutional investors held Merck (MRK) as of Q4 2013, up from 1,469 in Q3 2013.
  • Funds reported $109B of Merck stock for Q4 2013, up 5.7% quarter-over-quarter.
  • 187 funds opened new Merck positions in Q4 2013 and 70 closed out, a net change of +117 holders.
  • The largest Merck buyer in Q4 2013 was Capital World Investors, an estimated $561M added.
  • The largest Merck seller in Q4 2013 was Fidelity Investments, an estimated $386M sold.

Based on aggregated 13F filings for Q4 2013.